Sophiris Bio (SPHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||
| Net Income | -4,520 | -14,200 |
| Depreciation Amortization | 60 | 530 |
| Other Working Capital | -970 | 600 |
| Other Operating Activity | 1,150 | 730 |
| Operating Cash Flow | $-4,280 | $-12,340 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -9 | -250 |
| Other Investing Activity | 12 | 0 |
| Investing Cash Flow | $3 | $-250 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 7,980 | 23,510 |
| Financing Cash Flow | $7,980 | $23,510 |
| Exchange Rate Effect | -200 | 100 |
| Beginning Cash Position | 23,410 | 12,380 |
| End Cash Position | 26,900 | 23,410 |
| Net Cash Flow | $3,490 | $11,020 |
| Free Cash Flow | ||
| Operating Cash Flow | -4,280 | -12,340 |
| Free Cash Flow | -4,280 | -12,340 |